Hospital Clínic de Barcelona, officially Hospital Clínic i Provincial de Barcelona, is a university hospital founded in 1906 and based in Barcelona. It opened its doors on December 23, 1906, with a capacity of 400 patients, some of which were moved from Hospital de la Santa Creu.

There are 819 beds in Hospital Clinic, Hematology Department.

During the past decade, Hospital Clinic, Hematology Department conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Hospital Clinic, Hematology Department" are "Essential Thrombocythemia" (1 trials), "Myelofibrosis" (1 trials), "Myeloproliferative Neoplasm" (1 trials) and "Polycythemia Vera" (1 trials). Many other conditions were trialed in "Hospital Clinic, Hematology Department" in a lesser frequency.

Most popular intervention types in "Hospital Clinic, Hematology Department" are "Drug" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "DOACs" (1 trials) and "JAK2V617F mutation" (1 trials). Other intervention names were less common.

The vast majority of trials in "Hospital Clinic, Hematology Department" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Hospital Clinic, Hematology Department". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Hospital Clinic, Hematology Department, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Hospital Clinic, Hematology Department, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".